Fig. 5. Flow cytometry of the BCSCs and immunological markers . A. Histograms of flow cytometric analysis of CSCs markers; CD44, CD24, and SCa-1 as well as immune cells markers; CD117, CD62L, and CD4. Blood samples were collected from mice in the SEC/CDDP groups. B. One-way ANOVA was done (n = 5). Data are expressed as mean ± SD. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = nonsignificant. BCSCs: breast cancer stem cells, CD: cluster of differentiation, SCa-1: stem cell antigen 1, SEC: solid Ehrlich carcinoma, SEC/CDDP: cisplatin-resistant SEC, SEC/CDDP-CDDP: cisplatin-resistant SEC treated with cisplatin, SEC/CDDP-indomethacin: cisplatin-resistant SEC treated with indomethacin, SEC/CDDP-combination: cisplatin-resistant SEC treated with CDDP and indomethacin.